Gastrointestinal perforation in metastatic carcinoma: a complication of bevacizumab therapy. [electronic resource]
Producer: 20090323Description: 444-6 p. digitalISSN:- 1532-2157
- Abdominal Pain -- drug therapy
- Aged
- Angiogenesis Inhibitors -- adverse effects
- Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Carcinoma -- complications
- Confounding Factors, Epidemiologic
- Female
- Humans
- Intestinal Perforation -- chemically induced
- Male
- Middle Aged
- Wound Healing -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.